FWM
ABBV icon

Foguth Wealth Management’s AbbVie ABBV Stock Holding History

Foguth Wealth Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$368K Sell
1,452
-239
-14% -$51.4K 0.04% 150
2026
Q1 		$368K Buy
+1,691
New +$375K 0.04% 138

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Foguth Wealth Management's ABBV Position: Q2 2026 in Review

Foguth Wealth Management reduced its AbbVie (ABBV) stake by 14% in Q2 2026, selling an estimated $51.4K and leaving 1,452 shares worth $368K. The position accounts for 0.04% of the portfolio, ranked #150.

Foguth Wealth Management first reported a position in ABBV in Q1 2026 and has held it in 2 quarters since. The position peaked at $368K in Q1 2026. 4,193 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Foguth Wealth Management held 1,452 shares of AbbVie worth $368K as of Q2 2026.
  • Foguth Wealth Management sold 239 AbbVie shares in Q2 2026, an estimated $51.4K.
  • AbbVie made up 0.04% of Foguth Wealth Management's portfolio in Q2 2026, its #150 holding.
  • Foguth Wealth Management first reported a position in AbbVie in Q1 2026 and has held it in 2 quarters since.
  • Foguth Wealth Management's AbbVie position peaked at $368K in Q1 2026.
  • 4,193 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Foguth Wealth Management's 13F filing for Q2 2026, filed 21 Jul 2026.